Quarterly Results

  • Company Name :
Lupin Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 500257
  • NSE Symbol:
  • LUPIN
  • P/E(TTM):
  • 17.82
  • ISIN Demat:
  • INE326A01037
  • Div & Yield%:
  • 0.58
  • EPS(TTM):
  • 116.81
  • Book Value(₹):
  • 596.04
  • Market Cap(₹Cr.):
  • 95,052.21
  • Face Value(₹):
  • 2.00
Quarters :  
Particulars September 2025 ( Cr)June 2025 ( Cr)March 2025 ( Cr)
Gross Sales 3,852.79 5,605.41 4,382.69
Excise Duty 0.00 0.00 0.00
Net Sales 3,852.79 5,605.41 4,382.69
Other Operating Income 215.49 103.18 102.98
Other Income 662.68 54.14 48.79
Total Income 4,730.96 5,762.73 4,534.46
Total Expenditure 2,892.65 2,978.95 2,739.54
PBIDT 1,838.31 2,783.78 1,794.92
Interest 27.78 18.90 33.85
PBDT 1,810.53 2,764.88 1,761.07
Depreciation 174.72 176.73 207.98
Tax 287.23 451.54 270.25
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax -8.77 8.54 -8.51
Reported Profit After Tax 1,357.35 2,128.07 1,291.35
Extra-ordinary Items 488.61 0.00 0.00
Adjusted Profit After Extra-ordinary item 868.74 2,128.07 1,291.35
EPS (Unit Curr.) 18.42 46.60 28.30
EPS (Adj) (Unit Curr.) 18.42 46.60 28.30
Calculated EPS (Unit Curr.) 29.71 46.59 28.28
Calculated EPS (Adj) (Unit Curr.) 29.71 46.59 28.28
Calculated EPS (Ann.) (Unit Curr.) 118.86 186.37 113.13
Calculated EPS (Adj) (Ann.) (Unit Curr.) 118.86 186.37 113.13
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 91.36 91.35 91.32
Reserve & Surplus 0.00 0.00 0.00
Face Value 2.00 2.00 2.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 47.71 49.66 40.95
PBDTM(%) 46.99 49.33 40.18
PATM(%) 35.23 37.96 29.46